TITLE

ABS/RUSSIA FEDERATION SIGN VACCINE AGREEMENTS

PUB. DATE
January 2002
SOURCE
Worldwide Biotech;Jan2002, Vol. 14 Issue 1, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Deals with the agreement reached by American Biogenetic Sciences Inc. with the Ministry of Health of the Russian Federation in January 2002.
ACCESSION #
5935902

 

Related Articles

  • American Biogen files Chapter 7.  // Long Island Business News (7/1993 to 5/2009);9/27/2002, Vol. 49 Issue 41, p1A 

    Reports the filing of American Biogenetic Sciences Inc. for bankruptcy in Long Island, New York. Company history; Achievements; Possible reasons for the business failure; Products developed.

  • ABS closing in on $2B epilepsy market. Goldberg, Carol // Long Island Business News (7/1993 to 5/2009);08/24/98, Vol. 45 Issue 34, p5A 

    Reports on American Biogenetic Sciences Inc.'s search for a partner to co-develop ABS-103 therapy for epilepsy. Size of the market for the disease; Research deal with the United States National Institutes of Health; Curative properties of ABS-103.

  • ABS signs with UPR for biotechnology R&D. Martinez, Marialba // Caribbean Business;10/25/2001, Vol. 29 Issue 43, p19 

    Reports on the agreement between the School of Medicine of the University of Puerto Rico and the American Biogenetic Sciences Inc. in Ponce. Establishment of a research and development facility; Production of diagnostic and therapeutic technology for the treatment of cardiovascular disease and...

  • ABS AWARDED PATENT FOR TREATING AND PREVENTING MIGRAINE.  // Biotech Business;Nov2001, Vol. 14 Issue 11, p6 

    Reports on a patent granted by the United States Patent Office for the technology developed by the American Biogenetic Sciences, Inc. for treating and preventing migraine.

  • American Biogenetic gets patent.  // Long Island Business News (7/1993 to 5/2009);11/17/97, Vol. 44 Issue 46, p40 

    Reports that American Biogenetic Sciences Inc. has been issued a patent by the US Patent and Trademark Office related to a class of molecules for the potential treatment of neurodegenerative disorders. Development of molecules as oral pharmaceutical products; Research findings on organic...

  • Biogenetics firm atop 'Fast 50' Conroy, Michael P. // Long Island Business News (7/1993 to 5/2009);09/29/2000, Vol. 47 Issue 39, p5A 

    Focuses on the growth of Long Island, New York-based American Biogenetic Sciences. Emergence of the firm on top of Deloitte & Touche's list of 'Fast 50' high technology companies on Long Island, New York; Specialization in the manufacture of diagnostic testing equipment; Revenue in 1999.

  • Am Biogen in anthrax deal.  // Long Island Business News (7/1993 to 5/2009);1/25/2002, Vol. 49 Issue 4, p9A 

    Reports on the contract signed between American Biogenetic Sciences Inc. with a Russian association to distribute vaccines for anthrax and smallpox to be manufactured in Russia.

  • Fire in the veins. Markus, Stuart // Long Island Business News (7/1993 to 5/2009);10/13/2000, Vol. 47 Issue 41, p1A 

    Features the Copiague, New York-based American Biogenetic Sciences Inc. Acceptance of bids for its recently developed treatment for strokes, Alzheimer's and Parkinson's diseases; Profile on company chairman Alfred Roach; Diagnostic use of the Functional Intact Fibrinogen.

  • American Biogen sells Stellar, plans to fight Nasdaq delisting. Solnik, Claude // Long Island Business News (7/1993 to 5/2009);7/13/2001, Vol. 48 Issue 28, p8A 

    Reports on the decision of American Biogenetics Sciences Inc. to sell subsidiary Stellar Bio Systems Inc. to PanBio Limited. Effort of American Biogenetics to stop delisting from the Nasdaq Stock Exchange; Terms of the deal; Refocus on blood diagnostic and drug development business.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics